Basis: FMP quote market capitalization / revenue from four consecutive issuer fiscal quarters. Source: stored company filings and market data; unavailable inputs remain N/A.
The P/S ratio is N/A as of 2026-10-06T19:38:31.799Z.
Calculation as of: 2026-10-06T19:38:31.799Z.
Quote observation: 2026-10-06T19:30:00.000Z. Amounts in USD. The price header may show a later quote.
FMP input reference: 85c5299a8cd03ba6ccd909ec362e0e14be7ffdf82dbb7ad991ebf1e2cdc97105
Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation.
PS RATIO
N/A
Market Cap
$2.54M
PS Ratio
0.43
TTM Avg
0.51
3Y Avg
25.58
5Y Avg
970.72
Market Cap
$3.02M
PS Ratio
N/A
TTM Avg
71.18
3Y Avg
73.71
5Y Avg
73.71
| NAME | MARKET CAP | PS RATIO | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Universe Pharmaceuticals Inc. (UPC) | $2.75M | N/A | N/A | N/A | N/A |
| iSpecimen Inc. (ISPC)vs › | $2.72M | 5.83 | 1.16 | 0.59 | 1.24 |
| Nuwellis, Inc. (NUWE)vs › | $2.58M | 0.29 | 0.14 | 4.27 | 13.74 |
| Revelation Biosciences, Inc. (REVB)vs › | $3.20M | N/A | N/A | N/A | N/A |
| bioAffinity Technologies, Inc. (BIAF)vs › | $2.54M | 0.43 | 0.51 | 25.58 | 970.72 |
| Adagio Medical Holdings, Inc. (ADGM)vs › | $3.02M | N/A | 71.18 | 73.71 | 73.71 |
| Jaguar Health, Inc. (JAGX)vs › | $2.47M | 0.09 | 0.09 | 0.25 | 0.61 |
| Onconetix, Inc. (ONCO)vs › | $2.37M | 3.68 | 140.58 | 558.30 | 558.30 |
| FibroBiologics, Inc. Common Stock (FBLG)vs › | $2.38M | N/A | N/A | N/A | N/A |
| BioRestorative Therapies, Inc. (BRTX)vs › | $3.12M | 8.71 | 15.52 | 50.28 | 84.84 |
Half-year reporter: no trailing two-half-year basis, because the half-year figures cannot be checked against the annual report: the newest completed fiscal year's annual revenue and net income are both below 25 million, too small to compare.
The current P/S calculation cannot be reconciled from the stored quote and revenue inputs.
These references are supplied through FMP. Full filing context identifiers and dimensional metadata are unavailable in the normalized feed.
P/S Ratio
N/A
Market Cap / Trailing Twelve-Month Revenue
PS Ratio = Market Cap / Revenue (TTM)
The price-to-sales ratio compares market capitalization to trailing revenue. It is useful for valuing companies with little or no earnings.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
